Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Drug resistance in tuberculosis and options available.

Journal of the Indian Medical Association·2010

Same author

Quality DOTS management and empowering tuberculosis patients.

Journal of the Indian Medical Association·2009

Same author

IMA GFATM RNTCP PPM: gearing up to face ground realities.

Journal of the Indian Medical Association·2009

Same author

IMA GFATM RNTCP PPM project: milestones in sight one year after.

Journal of the Indian Medical Association·2008

Same author

An overview/update IMA GFATM RNTCP PPM project.

Journal of the Indian Medical Association·2008

Same author

IMA GFATM RNTCP PPM JIMR DOTS project.

Journal of the Indian Medical Association·2008

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

Paediatric tuberculosis and DOTS strategy under RNTCP.

Journal of the Indian Medical Association

|April 18, 2009

Summary

Tuberculosis in children is a significant concern, especially in developing nations. Diagnosis and treatment present challenges, but guidelines and innovations like RNTCP patientwise boxes aim to improve outcomes.

Area of Science:

Pediatrics
Infectious Diseases
Public Health

Background:

Tuberculosis (TB) infection in children primarily stems from adult exposure, with developing countries facing a 2-5% annual infection risk.
Children account for 8-20% of TB-related deaths, highlighting the severity of the disease in this demographic.
Diagnosing childhood TB is complex, often relying heavily on laboratory findings.

Purpose of the Study:

To outline diagnostic guidelines for suspected, probable, and confirmed childhood tuberculosis.
To recommend treatment regimens for pediatric TB patients within the Revised National Tuberculosis Control Program (RNTCP).
To address challenges including drug resistance and co-infection with HIV in childhood TB.

Main Methods:

Review and synthesis of existing guidelines for TB diagnosis in children.

More Related Videos

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Related Experiment Videos

Last Updated: Jun 23, 2026

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Discussion of treatment protocols recommended by TB experts and pediatricians.

Highlighting innovations such as patientwise drug boxes under RNTCP.

Main Results:

BCG vaccination effectively reduces disseminated and severe forms of TB in children.
RNTCP offers specific treatment regimens and patientwise boxes for various pediatric age groups and weights.
Drug resistance and HIV co-infection are critical considerations in managing childhood TB.

Conclusions:

Standardized guidelines and RNTCP regimens are crucial for effective childhood TB management.
Innovations like patientwise boxes improve adherence and treatment delivery.
Addressing drug resistance and HIV co-infection is essential for comprehensive pediatric TB control. Chemoprophylaxis is vital for asymptomatic children under six.